- Six drug classes treat allergic rhinitis — most patients use one or two; optimized care often uses two or three in combination
- Intranasal corticosteroids (Flonase, Nasacort) are the most effective single class for nasal symptoms
- Second-generation antihistamines (Claritin, Zyrtec, Allegra) are the most commonly used OTC class
- Leukotriene modifiers (Singulair) are underused despite good evidence, particularly for co-existing asthma
- Biologics (Dupixent) represent a new class for severe, treatment-resistant cases
Class 1: Intranasal Corticosteroids — The Most Effective Class
How they work: Corticosteroids act on glucocorticoid receptors in nasal mucosa cells, suppressing multiple inflammatory pathways simultaneously — reducing histamine release, decreasing mucosal swelling, and lowering the production of inflammatory mediators. Unlike antihistamines that block a single receptor type, corticosteroids address the full inflammatory cascade.
Why they're the most effective class: Head-to-head studies consistently show intranasal corticosteroids are more effective than antihistamines for nasal congestion and total nasal symptom scores. They reach full effect in 1-2 weeks of consistent use — which means starting them at season onset (or before) rather than waiting until symptoms are severe.
Common misuse: Using them intermittently "when bad days happen" rather than consistently. They don't work as fast-acting rescue medications — consistent daily use produces a steady-state reduction in mucosal inflammation that delivers most of the benefit.
Class 2: Oral Antihistamines — The Most Commonly Used Class
How they work: Block histamine H1 receptors, preventing histamine from triggering the symptoms it mediates. Second-generation versions are engineered to minimize blood-brain barrier penetration — reducing sedation compared to first-generation drugs.
Best for: Itching, sneezing, and runny nose. Less effective for nasal congestion than corticosteroids. Work rapidly (within 1 hour for most) and are appropriate for acute symptom management and consistent daily use during season.
The first vs second generation divide: Diphenhydramine (Benadryl) is significantly sedating, cognitively impairing, and should not be used for routine daytime allergy management. Second-generation options cause dramatically less impairment and are the appropriate daily-use choice. Among second-generation options, fexofenadine has the lowest sedation risk; cetirizine is the most likely to cause drowsiness.
Class 3: Intranasal Antihistamines — The Fast-Acting Nasal Option
How they work: Antihistamines delivered directly to nasal mucosa, providing faster onset than oral antihistamines (minutes vs hours) because they act locally rather than requiring absorption through the GI system. Can be used as needed for acute nasal symptom relief.
Best for: Rapid symptom breakthrough relief during known high-exposure events (outdoor activities during peak season, allergen exposure you can predict). Less appropriate as the primary daily medication due to cost and local side effects (bitter taste, drowsiness in some users).
Class 4: Decongestants — Relief for Congestion Specifically
How they work: Sympathomimetics that cause vasoconstriction of nasal blood vessels, reducing mucosal edema and opening nasal passages. They don't address the allergic mechanism — only the symptom of congestion.
Important limitations: Pseudoephedrine raises blood pressure and heart rate — contraindicated in hypertension, heart disease, and certain other conditions. Topical decongestants (Afrin) should not be used more than 3 days consecutively — rebound congestion (rhinitis medicamentosa) develops rapidly with longer use. Not appropriate for daily allergy season management; useful for acute severe congestion episodes.
Class 5: Leukotriene Modifiers — The Underused Option
How they work: Block leukotriene receptors — leukotrienes are inflammatory mediators released during allergic reactions that drive congestion, mucus production, and airway reactivity. Leukotriene modifiers are particularly effective for the nasal congestion and post-nasal drip that antihistamines often don't fully address.
Best for: Co-existing allergic rhinitis and asthma (leukotrienes drive both). People whose congestion responds poorly to antihistamines alone. Note: the FDA added a boxed warning in 2020 for neuropsychiatric side effects (mood changes, sleep disturbances, suicidal thoughts) — discuss with your doctor, particularly for children and people with psychiatric history.
Class 6: Biologics — The Newest Option for Severe Cases
How they work: Dupilumab blocks IL-4 and IL-13 — cytokines central to the Th2 allergic inflammatory pathway. It's a monoclonal antibody that addresses the underlying immune dysregulation rather than individual downstream mediators.
Best for: Severe, treatment-resistant allergic rhinitis with co-existing atopic dermatitis and/or asthma; patients who have failed multiple other drug classes; patients unable to tolerate corticosteroids. Not appropriate as a first-line treatment due to cost and injection delivery.
Pair the right medication with daily pollen intelligence.
Anthos tells you what's in your air before you decide which medication to reach for — and tracks your pollen threshold to show whether today warrants extra precautions.
Download on the App StoreRelated Guides
Anthos provides general wellness information only. Nothing in this article constitutes medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before making health decisions.